472 related articles for article (PubMed ID: 28877881)
1. Regulatory T cells in acute and chronic kidney diseases.
Sharma R; Kinsey GR
Am J Physiol Renal Physiol; 2018 May; 314(5):F679-F698. PubMed ID: 28877881
[TBL] [Abstract][Full Text] [Related]
2. Development and function of Foxp3(+) regulatory T cells.
Wang YM; Ghali J; Zhang GY; Hu M; Wang Y; Sawyer A; Zhou JJ; Hapudeniya DA; Wang Y; Cao Q; Zheng G; Harris DC; Alexander SI
Nephrology (Carlton); 2016 Feb; 21(2):81-5. PubMed ID: 26461175
[TBL] [Abstract][Full Text] [Related]
3. Macrophages in kidney injury, inflammation, and fibrosis.
Cao Q; Harris DC; Wang Y
Physiology (Bethesda); 2015 May; 30(3):183-94. PubMed ID: 25933819
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear phagocyte subpopulations in the mouse kidney.
George JF; Lever JM; Agarwal A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F640-F646. PubMed ID: 28100500
[TBL] [Abstract][Full Text] [Related]
6. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
7. mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.
Chen G; Dong Z; Liu H; Liu Y; Duan S; Liu Y; Liu F; Chen H
J Immunol; 2016 Nov; 197(10):3917-3926. PubMed ID: 27798166
[TBL] [Abstract][Full Text] [Related]
8. The Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis.
Nagashima R; Iyoda M
Front Immunol; 2021; 12():688647. PubMed ID: 34381446
[TBL] [Abstract][Full Text] [Related]
9. Research Progress on Regulatory T Cells in Acute Kidney Injury.
Wang Y; Tao Y
J Immunol Res; 2015; 2015():174164. PubMed ID: 26273681
[TBL] [Abstract][Full Text] [Related]
10. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
Front Immunol; 2021; 12():686530. PubMed ID: 34777330
[TBL] [Abstract][Full Text] [Related]
11. Renal tubule injury: a driving force toward chronic kidney disease.
Liu BC; Tang TT; Lv LL; Lan HY
Kidney Int; 2018 Mar; 93(3):568-579. PubMed ID: 29361307
[TBL] [Abstract][Full Text] [Related]
12. Immune cells and inflammation in AKI to CKD progression.
Sato Y; Yanagita M
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1501-F1512. PubMed ID: 30156114
[TBL] [Abstract][Full Text] [Related]
13. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
Stremska ME; Jose S; Sabapathy V; Huang L; Bajwa A; Kinsey GR; Sharma PR; Mohammad S; Rosin DL; Okusa MD; Sharma R
J Am Soc Nephrol; 2017 Sep; 28(9):2681-2693. PubMed ID: 28539382
[TBL] [Abstract][Full Text] [Related]
14. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
15. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.
Mehrotra P; Collett JA; McKinney SD; Stevens J; Ivancic CM; Basile DP
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F385-F397. PubMed ID: 27852609
[TBL] [Abstract][Full Text] [Related]
16. The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation.
Lv LL; Tang PM; Li CJ; You YK; Li J; Huang XR; Ni J; Feng M; Liu BC; Lan HY
Kidney Int; 2017 Mar; 91(3):587-602. PubMed ID: 28017324
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells in immune-mediated renal disease.
Ghali JR; Wang YM; Holdsworth SR; Kitching AR
Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury.
Lai LW; Yong KC; Lien YH
Kidney Int; 2012 May; 81(10):983-992. PubMed ID: 22189844
[TBL] [Abstract][Full Text] [Related]
19. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
20. T Lymphocytes in Acute Kidney Injury and Repair.
Gharaie Fathabad S; Kurzhagen JT; Sadasivam M; Noel S; Bush E; Hamad ARA; Rabb H
Semin Nephrol; 2020 Mar; 40(2):114-125. PubMed ID: 32303275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
